Literature DB >> 34176541

Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.

Gang Li1, Rafael S Rios1, Xin-Xin Wang2, Yue Yu2, Kenneth I Zheng1, Ou-Yang Huang1, Liang-Jie Tang1, Hong-Lei Ma1, Yi Jin3, Giovanni Targher4, Christopher D Byrne5, Xiao-Yan Pan6, Ming-Hua Zheng1,7,8.   

Abstract

Sarcopenic obesity is regarded as a risk factor for the progression and development of non-alcoholic fatty liver disease (NAFLD). Since male sex is a risk factor for NAFLD and skeletal muscle mass markedly varies between the sexes, we examined whether sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio (SVR), that is, an index of skeletal muscle mass combined with abdominal obesity, and the histological severity of NAFLD. The SVR was measured by bioelectrical impedance in a cohort of 613 (M/F = 443/170) Chinese middle-aged individuals with biopsy-proven NAFLD. Multivariable logistic regression and subgroup analyses were used to test the association between SVR and the severity of NAFLD (i.e. non-alcoholic steatohepatitis (NASH) or NASH with the presence of any stage of liver fibrosis). NASH was identified by a NAFLD activity score ≥5, with a minimum score of 1 for each of its categories. The presence of fibrosis was classified as having a histological stage ≥1. The SVR was inversely associated with NASH in men (adjusted OR 0·62; 95 % CI 0·42, 0·92, P = 0·017 for NASH, adjusted OR 0·65; 95 % CI 0·43, 0·99, P = 0·043 for NASH with the presence of fibrosis), but not in women (1·47 (95 % CI 0·76, 2·83), P = 0·25 for NASH, and 1·45 (95 % CI 0·74, 2·83), P = 0·28 for NASH with the presence of fibrosis). There was a significant interaction for sex and SVR (Pinteraction = 0·017 for NASH and Pinteraction = 0·033 for NASH with the presence of fibrosis). Our findings show that lower skeletal muscle mass combined with abdominal obesity is strongly associated with the presence of NASH only in men.

Entities:  

Keywords:  Appendicular skeletal muscle mass; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Presence of fibrosis; Sarcopenic obesity; Visceral fat area

Year:  2021        PMID: 34176541     DOI: 10.1017/S0007114521002415

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  4 in total

1.  Appendicular Skeletal Muscle Index and HbA1c Evaluate Liver Steatosis in Patients With Metabolic Associated Fatty Liver Disease.

Authors:  Rui Jin; Xiaoxiao Wang; Xiaohe Li; Jia Yang; Baiyi Liu; Lai Wei; Feng Liu; Huiying Rao
Journal:  Front Med (Lausanne)       Date:  2022-07-06

Review 2.  Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease.

Authors:  Xin-Lei Zhang; Ting-Yao Wang; Giovanni Targher; Christopher D Byrne; Ming-Hua Zheng
Journal:  Diabetes Metab J       Date:  2022-05-25       Impact factor: 5.893

3.  Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease.

Authors:  Wen Guo; Xin Zhao; Mengyuan Miao; Xiuru Liang; Xiaona Li; Pei Qin; Jing Lu; Wenfang Zhu; Juan Wu; Chen Zhu; Nianzhen Xu; Qun Zhang
Journal:  Front Nutr       Date:  2022-04-26

4.  PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease.

Authors:  Gang Li; Liang-Jie Tang; Pei-Wu Zhu; Ou-Yang Huang; Rafael S Rios; Kenneth I Zheng; Sui-Dan Chen; Hong-Lei Ma; Giovanni Targher; Christopher D Byrne; Xiao-Yan Pan; Ming-Hua Zheng
Journal:  J Clin Transl Hepatol       Date:  2021-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.